This thesis makes the case for an investment in Recursion Pharmaceuticals operating as a TechBio which "industrializes" the process of drug discovery in contrast to a typical biotech. The difference ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback